Clinical Trial: Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders

U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07254988) titled 'Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders' on Nov. 19.

Brief Summary: Both GIP and GLP-2 reduce bone resorption (measured as CTX) in healthy adult individuals. In this study, we will investigate whether GIP and GLP-2 reduce CTX in children with spinal muscular atrophy, duchenne muscular dystrophy, or cerebral palsy.

Study Start Date: March 24, 2023

Study Type: INTERVENTIONAL

Condition: Spinal Muscular Atrophy (SMA) Cerebral Palsy (CP) Duchenne Muscular Dystrophy (DMD)

Intervention: OTHER: Meal test

Ingestion of an oral liquid meal (nutridrink), 3.3 mL/kg body weight.

OTHER: GIP + GLP-2

Subcut...